Sientra Silicone Gel Breast Implants
Tiger Aesthetics Medical, LLC · Decision date Nov 4, 2026
What did the FDA approve?
FDA records P070004/S049 as a supplement to PMA P070004, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Nov 4, 2026.
FDA approval order statement
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of the premarket approval application (PMA) supplement, which requested approval for labeling updates to enhance safety in the use of the implants. The submission meets the criteria in 21 CFR 814.39(d)(2) for a "Special PMA Supplement - Changes Being Effected." Based upon the information submitted, the PMA supplement is approved.
- Regulatory pathway
- PMA supplement
- Supplement type
- Special (Immediate Track)
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Nov 4, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P070004/S049
- Regulatory pathway
- PMA supplement
- Applicant
- Tiger Aesthetics Medical, LLC
- Product code
- FTR
- Decision code
- APPR
- Decision date
- Nov 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.
- Applicant
- Tiger Aesthetics Medical, LLC
- Product code
- FTR
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P070004. Subsequent supplements may change the device or its indications.
FDA decision timeline
P070004 · Original PMA
SIENTRA SILICONE GEL BREAST IMPLANTS
P070004/S049 received
Application receipt date recorded by FDA.
P070004/S049 · FDA decision
Special (Immediate Track)
Timeline entries are records held by MedtechLedger for P070004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P070004
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Tiger Aesthetics Medical, LLC | PMA approval | Mar 9, 2012 | FDA |
Explore the linked device profile
Other records with product code FTR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MemoryGel Breast ImplantsP030053/S093 | Mentor Corp. | PMA supplement | Oct 23, 2026 | FDA |
MemoryShape Breast ImplantsP060028/S063 | Mentor Worldwide, LLC | PMA supplement | Oct 23, 2026 | FDA |
| Motiva USA, LLC | PMA supplement | Oct 2, 2026 | FDA | |
| Allergan | PMA supplement | Sep 29, 2026 | FDA | |
| Motiva USA, LLC | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tiger Aesthetics Medical, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9779 S. Franklin Dr., Suite 300, Franklin, WI, 53132
Sources and methodology
- Original FDA record: P070004/S049
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


